HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Challenges of managing sympathetic ophthalmia in a young child and the role of infliximab.

Abstract
The authors report the difficult challenges and use of infliximab in the delayed presentation of a 2½-year-old boy with a penetrating eye injury from a small ballpoint pen that led to sympathetic ophthalmia.
AuthorsKimia Ziahosseini, William D Newman
JournalJournal of pediatric ophthalmology and strabismus (J Pediatr Ophthalmol Strabismus) Vol. 48 Online Pg. e34-6 (Jul 06 2011) ISSN: 1938-2405 [Electronic] United States
PMID21732578 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright 2011, SLACK Incorporated.
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Glucocorticoids
  • Immunosuppressive Agents
  • Infliximab
  • Methylprednisolone
  • Methotrexate
Topics
  • Accidents, Home
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Cataract (etiology)
  • Cataract Extraction
  • Child, Preschool
  • Drug Therapy, Combination
  • Eye Injuries, Penetrating (diagnosis, drug therapy, etiology)
  • Glucocorticoids (therapeutic use)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Infliximab
  • Infusions, Intravenous
  • Iris (injuries)
  • Lens Implantation, Intraocular
  • Male
  • Methotrexate (therapeutic use)
  • Methylprednisolone (therapeutic use)
  • Ophthalmia, Sympathetic (diagnosis, drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: